|
Status |
Public on Sep 02, 2024 |
Title |
Degradation of Ikaros prevents epigenetic progression of T cell exhaustion in novel antigen-specific assay [bulk ATAC-seq] |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
Epigenetic regulation drives the differentiation of T cells into phenotypically stable subsets including a dysfunctional state termed exhaustion, the presence of these epigenetically distinct T cells in tumors make them non-responsive to checkpoint blockade. Cancer immunotherapies restoring T cell function have transformed cancer treatment by preventing immune evasion of tumor cells allowed by T cell exhaustion. However, some patients develop resistance to immunotherapy or do not respond. Recent literature has demonstrated that epigenetic regulation governs the transition from effector to exhausted T cells. Here, we describe a novel antigen-specific assay for T-cell exhaustion that produces T cells biologically and epigenetically similar to their in vivo exhausted counterpart. We perform a CRISPR KO screen for epigenetic regulators of the human genome and validate Ikaros as a driver of T-cell exhaustion. We determined that the Ikaros degrader iberdomide prevents exhaustion by blocking chromatin remodeling at T cell effector enhancers by preserving activity of key transcription factors AP-1, NF-κB and NFAT using transcription factor footprinting analysis. Thus, our study uncovers a role for Ikaros, degraded by the drug iberdomide, as a driver of T-cell exhaustion.
|
|
|
Overall design |
SHARE-seq to profile chromatin accessibility and gene expression in T cells from four healthy human donors. Donor PBMCs were expanded for antigen-specific T cells using viral peptide cocktail over the course of 7 or 14 days. Iberdomide or DMSO was used to treat cells from day 7 -14.
|
|
|
Contributor(s) |
Tay T, Bommakanti G |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Sep 27, 2023 |
Last update date |
Sep 02, 2024 |
Contact name |
Tristan Tay |
E-mail(s) |
taytristan@gmail.com, ttay@g.harvard.edu
|
Organization name |
Harvard University
|
Department |
Stem Cell & Regenerative Biology
|
Lab |
Buenrostro
|
Street address |
7 Divinity Avenue
|
City |
Cambridge |
State/province |
MA |
ZIP/Postal code |
02138 |
Country |
USA |
|
|
Platforms (1) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (11)
|
|
This SubSeries is part of SuperSeries: |
GSE244184 |
Degradation of Ikaros prevents epigenetic progression of T cell exhaustion in novel antigen-specific assay |
|
Relations |
BioProject |
PRJNA1021618 |